Company Rivapharm Srl with Fiscal Code 14280474
recorded a turnover of 2024 of
473.667,
with a net profit of
4.000
and having an average number of employees of
8.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Rivapharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
334.370
357.738
375.681
437.620
455.297
491.388
432.503
478.660
502.776
473.667
Total Income - EUR
337.489
360.228
379.924
458.659
461.709
492.910
434.037
483.922
510.840
475.356
Total Expenses - EUR
358.478
350.202
369.036
449.961
453.679
478.127
427.780
478.524
499.822
470.684
Gross Profit/Loss - EUR
-20.990
10.026
10.888
8.698
8.030
14.784
6.256
5.398
11.017
4.672
Net Profit/Loss - EUR
-20.990
8.421
6.032
5.336
6.745
12.560
6.256
5.398
6.152
4.000
Employees
10
9
11
10
9
10
10
10
10
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -5.3%, from 502.776 euro in the year 2023, to 473.667 euro in 2024.
The Net Profit decreased by -2.117 euro, from 6.152 euro in 2023, to 4.000 in the last year.
Check the financial reports for the company - Rivapharm Srl
Financial Rating - RIVAPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Rivapharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Rivapharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Rivapharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
154.559 euro in 2024 which includes Inventories of
54.227 euro, Receivables of
93.042 euro and cash availability of
-1.757 euro.
The company's Equity was valued at
135.562 euro, while total Liabilities amounted to
87.955 euro.
Equity increased by 4.000 euro, from 132.301 euro in 2023, to 135.562 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Rivapharm Srl